Crl Predictions & Odds· 160 markets

L
LoL: paiN Gaming vs RED Canids (BO5) - CBLOL Playoffs

Esports · league of legends

LoL: paiN Gaming vs RED Canids (BO5) - CBLOL Playoffs

48%

paiN Gaming

$63k Vol.
$444k Liq.
🔥$63k today
Ends in about 7 hours
L
LoL: The Bandits vs Dynasty (BO3) - Road Of Legends Regular Season

Esports · league of legends

LoL: The Bandits vs Dynasty (BO3) - Road Of Legends Regular Season

$68k Vol.
$0 Liq.
Ended
L
LoL: Unicorns Of Love Sexy Edition vs ROSSMANN Centaurs (BO5) - Prime League 1st Division Playoffs
$700k Vol.
$0 Liq.
Ended
W
Will Charles River (CRL) beat quarterly earnings?

Yes

$4k Vol.
$0 Liq.
Ended
F
FDA approvals in July

FDA approvals in July

TransCon hGH (sBLA)

$108k Vol.
$0 Liq.
12
Ended
C
Counter-Strike: Noir Verse vs Atreides (BO3) - ESL Challenger League Europe Cup #5 Group C

Atreides

$88k Vol.
$0 Liq.
Ended
C
Counter-Strike: Noir Verse vs Dark Moon (BO3) - ESL Challenger League Europe Cup #6 Group B

Dark Moon

$2k Vol.
$0 Liq.
Ended
C
Counter-Strike: Atreides vs Noir Verse (BO3) - ESL Challenger League Europe Cup #5 Group C

Noir Verse

$63k Vol.
$0 Liq.
Ended
C
Counter-Strike: Gothic vs A Great Chaos (BO3) - ESL Challenger League Europe Cup #6 Group A

A Great Chaos

$5k Vol.
$0 Liq.
Ended
C
Counter-Strike: Noir Verse vs Fortress (BO3) - ESL Challenger League Europe Cup #2 Group C

Noir Verse

$20k Vol.
$0 Liq.
Ended
F
FDA approves FILSPARI REMS modification?

Yes

$1k Vol.
$0 Liq.
12
Ended
F
FDA approves MannKind's FUROSCIX ReadyFlow Autoinjector?

Yes

$778 Vol.
$0 Liq.
Ended
C
Counter-Strike: WRAITH PCIFIC vs Atreides (BO3) - ESL Challenger League Europe Cup #5 Group C

Atreides

$45k Vol.
$0 Liq.
Ended
F
FDA approves Arcalyst technology transfer?

No

$6k Vol.
$0 Liq.
Ended
L
LoL: LOUD vs RED Canids (BO3) - CBLOL Regular Season

Esports · league of legends

LoL: LOUD vs RED Canids (BO3) - CBLOL Regular Season

LOUD

$269k Vol.
$0 Liq.
Ended
V
Valorant: AB3 Esports vs Chivas Esports (BO3) - VCL Latin America North Group Stage

Chivas Esports

$0 Vol.
$0 Liq.
Ended